Initial efforts to generate GEMMs of ccRCC focused on inactivation of Vhl in mice, since biallelic inactivation of VHL is present in over 90% of sporadic ccRCC in humans (28, 110–112). This evidence concerns the gene VHL and nonpapillary renal cell carcinoma.